|
⚲
|
| Keyboard |
| Barbara Dalton | |
|---|---|
| Firm | |
| Address | c/o Petra Pharma Corporation 450 E 29th St, Suite 506 New York, NY 10016 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Complexa Inc | 021-337393 | Director | 11.0 M of 28.0 M |
||
| Imara Inc | 021-336073 | Director | 44.1 M of 63.0 M |
||
| Morphic Holding LLC | 021-322473 | Director | 80.0 M of 80.0 M |
||
| Petra Pharma Corp | 021-321233 | Director | 27.5 M of 27.5 M |
||
| Magnolia Neurosciences Corp | 021-319505 | Director | 8.0 M of 13.1 M |
||
| Cydan II Inc | 021-296407 | Director | 10.7 M of 34.0 M |
||
| Complexa Inc | 021-291504 | Director | 40.6 M of 62.6 M |
||
| Morphic Holding LLC | 021-266861 | Director | 20.6 M of 51.5 M |
||
| Imara Inc | 021-261834 | Director | 6.0 M of 31.0 M |
||
| Petra Pharma Corp | 021-254662 | Director | 31.2 M of 48.2 M |
||
| LODO Therapeutics Corp | 021-254438 | Director | 19.9 M of 19.9 M |
||
| Celladon Corp | 021-205300 | Director | 1.1 M of 2.4 M |
||
| Cydan LLC | 021-194829 | Director | 6.6 M of 26.3 M |
||
| Celladon Corp | 021-172955 | Director | 19.5 M of 64.5 M |
||